Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportPreclinical Probes for Oncology

Arylhalide Albumin Binder-Mediated Extended Circulation Imparts Longer Tumor Retention of [177Lu]-LLP2A Conjugates in VLA-4 Expressing Murine Melanoma

Aron Roxin, Chengcheng Zhang, Jutta Zeisler, Nadine Colpo, Xinchi Hou, Carlos Uribe, Zhengxing Zhang, Kuo-Shyan Lin and Francois Benard
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 2863;
Aron Roxin
1University of British Columbia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chengcheng Zhang
2BC Cancer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jutta Zeisler
2BC Cancer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nadine Colpo
3BC Cancer - Vancouver
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xinchi Hou
1University of British Columbia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Uribe
2BC Cancer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhengxing Zhang
2BC Cancer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kuo-Shyan Lin
2BC Cancer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francois Benard
4BC Cancer Research Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 63 no. supplement 2 2863

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 8, 2022.

Copyright & Usage 
© 2022

Author Information

  1. Aron Roxin1,
  2. Chengcheng Zhang2,
  3. Jutta Zeisler2,
  4. Nadine Colpo3,
  5. Xinchi Hou1,
  6. Carlos Uribe2,
  7. Zhengxing Zhang2,
  8. Kuo-Shyan Lin2 and
  9. Francois Benard4
  1. 1University of British Columbia
  2. 2BC Cancer
  3. 3BC Cancer - Vancouver
  4. 4BC Cancer Research Institute

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: August 2022 to April 2025

AbstractFullPdf
Aug 20222200
Sep 2022900
Oct 20221500
Nov 2022900
Dec 2022900
Jan 20232200
Feb 20231100
Mar 20231200
Apr 2023800
May 20231300
Jun 20231000
Jul 20231300
Aug 2023800
Sep 20233500
Oct 2023400
Nov 2023100
Dec 20231800
Jan 2024600
Feb 2024800
Mar 2024400
Apr 20244500
May 20243400
Jun 20242400
Jul 202411200
Aug 20249700
Sep 20241800
Oct 2024900
Nov 2024700
Dec 2024600
Feb 2025400
Mar 2025700
Apr 2025700
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Arylhalide Albumin Binder-Mediated Extended Circulation Imparts Longer Tumor Retention of [177Lu]-LLP2A Conjugates in VLA-4 Expressing Murine Melanoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Arylhalide Albumin Binder-Mediated Extended Circulation Imparts Longer Tumor Retention of [177Lu]-LLP2A Conjugates in VLA-4 Expressing Murine Melanoma
Aron Roxin, Chengcheng Zhang, Jutta Zeisler, Nadine Colpo, Xinchi Hou, Carlos Uribe, Zhengxing Zhang, Kuo-Shyan Lin, Francois Benard
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2863;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Arylhalide Albumin Binder-Mediated Extended Circulation Imparts Longer Tumor Retention of [177Lu]-LLP2A Conjugates in VLA-4 Expressing Murine Melanoma
Aron Roxin, Chengcheng Zhang, Jutta Zeisler, Nadine Colpo, Xinchi Hou, Carlos Uribe, Zhengxing Zhang, Kuo-Shyan Lin, Francois Benard
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2863;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 89Zr-labeled anti-B7-H3 antibody for evaluating in vivo B7-H3 levels in a pulmonary melanoma mouse model
  • Novel radiotracer targeting LDLR-overexpressing glioblastoma and pancreatic ductal adenocarcinoma – preclinical and dosimetry studies
  • Evaluation of dual-receptor targeted 68Ga-NGR-RGD in 8 different subcutaneous and orthotopic tumor models
Show more Preclinical Probes for Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire